Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community M30, month 2 of dutasteride and minoxidil

      in Progress Pictures  275 upvotes 9 months ago
      A user shared their two-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects and increased sex drive. Other users discussed their experiences with similar treatments, including finasteride and oral minoxidil, and debated the effectiveness of microneedling.

      community Research behind RU-58642? Has anyone heard of this?

      in Research/Science  1 upvotes 10 months ago
      RU-58642 is a powerful anti-androgen that was not developed further, possibly due to safety concerns or financial reasons. RU58841 is a topical alternative, but it is less effective than finasteride and dutasteride, and its long-term effects are not well-studied.

      community Breezula(CB)Phase3Results Date

      in Research/Science  7 upvotes 1 year ago
      Breezula's phase 3 results are expected in July or August, with commercialization possibly in two years. There are concerns about delays and effectiveness, and the cost may be high.

      community 16 months of treatment and a frontal transplant changed my life!!

      in Progress Pictures  638 upvotes 2 months ago
      A 30-year-old shared their successful hair restoration journey using liposomal topical finasteride and minoxidil, vitamins, and a second hair transplant in Greece, which significantly improved their hair density without side effects. The transplant cost $7500 and involved filling an old scar, with the user expressing gratitude for the life-changing results.

      community Pyrilutamide Phase 3 on its way

      in Treatment  129 upvotes 4 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.

      community Disappointing news on Breezula/CB-03-01

       18 upvotes 7 years ago
      The conversation discusses disappointment over only receiving a financial report from Cassiopea instead of trial results for Breezula/CB-03-01, a hair loss treatment. However, there is optimism as the company is advancing Breezula into Phase III trials for men, starting trials for women, and submitting an NDA for their acne product, Winlevi.